Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Aside from preemption, it is quite possible that no legal doctrine has caused more angst to both sides of the pharmaceutical product liability bar, and in turn, the courts, than the interplay of negligence versus strict liability and the viability of a design defect claim against manufacturers of FDA-approved prescription drugs. At the heart of this debate is “comment k” of the Restatement (Second) of Torts, a provision written almost 50 years ago by the American Law Institute (ALI). See Restatement (Second) of Torts ' 402A, comment k (1965).
In the past year, two much-anticipated decisions, one from the U.S. Supreme Court and one from the Supreme Court of Pennsylvania, stand at opposite ends of the spectrum on the viability of design defect claims against manufacturers of prescription drugs. In June 2013, the U.S. Supreme Court decided Mutual Pharm. Co. v. Bartlett, 133 S. Ct. 2466 (2013), holding that state law design defect claims against generic manufacturers of prescription drugs are preempted under federal law. This past January, the Pennsylvania Supreme Court decided Lance v. Wyeth, 2014 Pa. LEXIS 205 (Pa. Jan. 21, 2014), holding that design defect claims grounded in negligence can proceed against manufacturers of prescription drugs, side-stepping 20-year-old precedent barring strict liability design defect claims under Pennsylvania law.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
On Aug. 9, 2023, Gov. Kathy Hochul introduced New York's inaugural comprehensive cybersecurity strategy. In sum, the plan aims to update government networks, bolster county-level digital defenses, and regulate critical infrastructure.
A trend analysis of the benefits and challenges of bringing back administrative, word processing and billing services to law offices.
Summary Judgment Denied Defendant in Declaratory Action by Producer of To Kill a Mockingbird Broadway Play Seeking Amateur Theatrical Rights
When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.